114 related articles for article (PubMed ID: 37094224)
1. A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia.
Itakura T; Sasaki H; Hosoya T; Yamaguchi T; Mimori E; Saimon Y; Iwai H; Umezawa N; Kawata D; Kimura N; Kurata M; Shimizu M; Yasuda S
Rheumatology (Oxford); 2023 Nov; 62(11):e319-e321. PubMed ID: 37094224
[No Abstract] [Full Text] [Related]
2. A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B-cell lymphopenia.
Park HS; Oh A; Keum CW; Lee J; Lee JK; Son BR; Shin KS; Hahn YS
Eur J Med Genet; 2022 Jan; 65(1):104387. PubMed ID: 34768012
[TBL] [Abstract][Full Text] [Related]
3. Variant in the
Welzel T; Oefelein L; Holzer U; Müller A; Menden B; Haack TB; Groβ M; Kuemmerle-Deschner JB
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35955991
[TBL] [Abstract][Full Text] [Related]
4. A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran.
Khabbazi A; Rahbar Kafshboran H; Nasiri Aghdam M; Nouri Nojadeh J; Daghagh H; Daneshmandpour Y; Kazemzadeh M; Hamzeiy H; Sakhinia E
Immunol Lett; 2020 May; 221():27-32. PubMed ID: 32014489
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C-Gamma 2 Activity in Familial Steroid-Sensitive Nephrotic Syndrome.
Parker L; Bahat H; Appel MY; Baum DV; Forer R; Pillar N; Goldberg M; Goldman M
Pediatr Res; 2019 Apr; 85(5):719-723. PubMed ID: 30568185
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
Magno L; Lessard CB; Martins M; Lang V; Cruz P; Asi Y; Katan M; Bilsland J; Lashley T; Chakrabarty P; Golde TE; Whiting PJ
Alzheimers Res Ther; 2019 Feb; 11(1):16. PubMed ID: 30711010
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological features of an APLAID patient caused by a novel mutation in
Peng Q; Luo D; Yang Y; Zhu Y; Luo Q; Chen H; Chen D; Zhou Z; Lu X
Front Immunol; 2023; 14():1014150. PubMed ID: 36776842
[TBL] [Abstract][Full Text] [Related]
8. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
Strickland SL; Morel H; Prusinski C; Allen M; Patel TA; Carrasquillo MM; Conway OJ; Lincoln SJ; Reddy JS; Nguyen T; Malphrus KG; Soto AI; Walton RL; Crook JE; Murray ME; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Uitti RJ; Wszolek ZK; Ross OA; Graff-Radford NR; Dickson DW; Ertekin-Taner N
Acta Neuropathol Commun; 2020 Oct; 8(1):172. PubMed ID: 33092647
[TBL] [Abstract][Full Text] [Related]
9. Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever.
Schlabe S; Schwarze-Zander C; Lohse P; Rockstroh JK
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27899390
[TBL] [Abstract][Full Text] [Related]
10. A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel.
Xiong J; Chen S; Chen B; Zhang W; Chen C; Deng X; He F; Zhang C; Yang L; Wang Y; Peng J; Yin F
Clin Chim Acta; 2022 May; 530():74-80. PubMed ID: 35247435
[TBL] [Abstract][Full Text] [Related]
11. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
[TBL] [Abstract][Full Text] [Related]
12. Severe epidermolysis bullosa/Kindler syndrome-like phenotype of an autoinflammatory syndrome in a child.
Mahajan R; Bishnoi A; Manjunath S; Vignesh P; Suri D; Gopal M; Chatterjee D; Jamwal M; De D; Das R; Handa S; Kubba A; Batrani M; Radotra BD
Clin Exp Dermatol; 2021 Jun; 46(4):795-799. PubMed ID: 33625737
[TBL] [Abstract][Full Text] [Related]
13. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.
Conway OJ; Carrasquillo MM; Wang X; Bredenberg JM; Reddy JS; Strickland SL; Younkin CS; Burgess JD; Allen M; Lincoln SJ; Nguyen T; Malphrus KG; Soto AI; Walton RL; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Cheshire WP; van Gerpen JA; Uitti RJ; Wszolek ZK; Ross OA; Dickson DW; Graff-Radford NR; Ertekin-Taner N
Mol Neurodegener; 2018 Oct; 13(1):53. PubMed ID: 30326945
[TBL] [Abstract][Full Text] [Related]
14. Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure.
Gerasimavicius L; Livesey BJ; Marsh JA
Nat Commun; 2022 Jul; 13(1):3895. PubMed ID: 35794153
[TBL] [Abstract][Full Text] [Related]
15. Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Wu N; Zhang B; Wang T; Shen M; Zeng X
Front Immunol; 2021; 12():667430. PubMed ID: 34093563
[TBL] [Abstract][Full Text] [Related]
16. A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases.
Novice T; Kariminia A; Del Bel KL; Lu H; Sharma M; Lim CJ; Read J; Lugt MV; Hannibal MC; O'Dwyer D; Hosler M; Scharnitz T; Rizzo JM; Zacur J; Priatel J; Abdossamadi S; Bohm A; Junker A; Turvey SE; Schultz KR; Rozmus J
J Clin Immunol; 2020 Feb; 40(2):267-276. PubMed ID: 31853824
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutation in complement C2 protein identified in a patient with aHUS.
Urban A; Volokhina E; Felberg A; Stasiłojć G; Blom AM; Jongerius I; van den Heuvel L; Thiel M; Ołdziej S; Arjona E; de Córdoba SR; Okrój M
J Allergy Clin Immunol; 2020 Oct; 146(4):916-919.e11. PubMed ID: 32113979
[No Abstract] [Full Text] [Related]
18. Recapitulation of the EEF1A2 D252H neurodevelopmental disorder-causing missense mutation in mice reveals a toxic gain of function.
Davies FCJ; Hope JE; McLachlan F; Marshall GF; Kaminioti-Dumont L; Qarkaxhija V; Nunez F; Dando O; Smith C; Wood E; MacDonald J; Hardt O; Abbott CM
Hum Mol Genet; 2020 Jun; 29(10):1592-1606. PubMed ID: 32160274
[TBL] [Abstract][Full Text] [Related]
19. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.
López-Granados E; Cambronero R; Ferreira A; Fontán G; García-Rodríguez MC
Clin Exp Immunol; 2003 Jul; 133(1):123-31. PubMed ID: 12823286
[TBL] [Abstract][Full Text] [Related]
20. SCN9A Epileptic Encephalopathy Mutations Display a Gain-of-function Phenotype and Distinct Sensitivity to Oxcarbazepine.
Zhang S; Zhang Z; Shen Y; Zhu Y; Du K; Guo J; Ji Y; Tao J
Neurosci Bull; 2020 Jan; 36(1):11-24. PubMed ID: 31372899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
